Before the hearing began, Sandra Steingraber, a leader of New Yorkers Against Fracking, confronted Martens and demanded the environmental review and regulations be put on hold and a comprehensive health impact analysis be done by an independent investigator.
Experts say it isn't viable for drug companies that spend millions developing a new antibiotic medicine then to be told by regulators to hold it in reserve for the next emergency.